Nanotechnology has emerged as a revolutionary frontier in pharmaceuticals, particularly in the realm of diagnosis. This cutting-edge technology involves manipulating materials at the nanoscale, typically ranging from 1 to 100 nanometers, to create novel structures and devices with unique properties. In the pharmaceutical sector, nanotechnology holds immense promise for diagnostic applications. Nanoscale materials can be engineered to interact with biological systems in highly specific ways, enabling the development of advanced diagnostic tools with unprecedented precision.
Nanoparticles, for instance, can be functionalized with targeting ligands to selectively bind to specific biomarkers associated with diseases. This targeted approach enhances the sensitivity and accuracy of diagnostic tests, allowing for early and more reliable detection of various medical conditions. Furthermore, nanoscale diagnostic agents can be designed to traverse biological barriers, enabling non-invasive imaging and detection at the molecular level. As nanotechnology continues to advance, its integration into pharmaceutical diagnostics is poised to revolutionize the field, offering more effective and personalized diagnostic solutions for improved patient outcomes.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand